Flag­ship un­wraps new AI biotech that looks to pre­dict vari­ants be­fore they’re here

While Mod­er­na is test­ing Omi­cron-spe­cif­ic boost­ers for this fall, its in­vestor Flag­ship Pi­o­neer­ing is build­ing a biotech that says it us­es AI to pre­dict virus …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER